Role of Natural Products in Modulating Histone Deacetylases in Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Natural Products in Modulating Histone Deacetylases in Cancer
Authors
Keywords
-
Journal
MOLECULES
Volume 24, Issue 6, Pages 1047
Publisher
MDPI AG
Online
2019-03-19
DOI
10.3390/molecules24061047
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting activator protein 1 signaling pathway by bioactive natural agents: Possible therapeutic strategy for cancer prevention and intervention
- (2018) Devesh Tewari et al. PHARMACOLOGICAL RESEARCH
- Pro-Apoptotic and Anti-Cancer Properties of Diosgenin: A Comprehensive and Critical Review
- (2018) Gautam Sethi et al. Nutrients
- Heliomycin and tetracinomycin D: anthraquinone derivatives with histone deacetylase inhibitory activity from marine sponge-associated Streptomyces sp. SP9
- (2018) Mohamed Saleh Abdelfattah et al. 3 Biotech
- Heliomycin and tetracinomycin D: anthraquinone derivatives with histone deacetylase inhibitory activity from marine sponge-associated Streptomyces sp. SP9
- (2018) Mohamed Saleh Abdelfattah et al. 3 Biotech
- Molecular Targets Modulated by Fangchinoline in Tumor Cells and Preclinical Models
- (2018) Myriam Mérarchi et al. MOLECULES
- Potential Anti-Inflammatory and Anti-Cancer Properties of Farnesol
- (2018) Young Jung et al. MOLECULES
- The Role of Resveratrol in Cancer Therapy
- (2017) Jeong-Hyeon Ko et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of novel histone modifications in cancer
- (2017) Muthu K. Shanmugam et al. Oncotarget
- Knockdown of HDAC1 expression suppresses invasion and induces apoptosis in glioma cells
- (2017) Xiao-Qiang Wang et al. Oncotarget
- Belinostat and vincristine demonstrate mutually synergistic cytotoxicity associated with mitotic arrest and inhibition of polyploidy in a preclinical model of aggressive diffuse large B cell lymphoma
- (2016) Aaron P. Havas et al. CANCER BIOLOGY & THERAPY
- Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer
- (2016) Mahmoud Alhosin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Epigenetic changes in histone acetylation underpin resistance to the topoisomerase I inhibitor irinotecan
- (2016) Cornelia Meisenberg et al. NUCLEIC ACIDS RESEARCH
- Aberrant lysine acetylation in tumorigenesis: Implications in the development of therapeutics
- (2016) Stephanie Kaypee et al. PHARMACOLOGY & THERAPEUTICS
- Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells
- (2016) Seung Ho Baek et al. PHYTOMEDICINE
- A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells
- (2016) Rishabh Kala et al. PLoS One
- The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer
- (2016) Øystein Helland et al. PLoS One
- Bioactive natural products in cancer prevention and therapy: Progress and promise
- (2016) Anupam Bishayee et al. SEMINARS IN CANCER BIOLOGY
- Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds
- (2016) Muthu K Shanmugam et al. SEMINARS IN CANCER BIOLOGY
- Targeting arachidonic acid pathway by natural products for cancer prevention and therapy
- (2016) Nagendra Sastry Yarla et al. SEMINARS IN CANCER BIOLOGY
- HDACs and HDAC Inhibitors in Cancer Development and Therapy
- (2016) Yixuan Li et al. Cold Spring Harbor Perspectives in Medicine
- Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer
- (2015) Swati Dhar et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- CDKN1A histone acetylation and gene expression relationship in gastric adenocarcinomas
- (2015) Fernanda Wisnieski et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Promoter methylation-independent reactivation of PAX1 by curcumin and resveratrol is mediated by UHRF1
- (2015) Gaurav Parashar et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Potential Prognostic Value of Histone Deacetylase 6 and Acetylated Heat-Shock Protein 90 in Early-Stage Breast Cancer
- (2015) Younghee Park et al. Journal of Breast Cancer
- Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer
- (2015) Jens U. Marquardt et al. JOURNAL OF HEPATOLOGY
- Marine Actinomycetes as potential source for histone deacetylase inhibitors and epigenetic modulation
- (2015) T.A. Varghese et al. LETTERS IN APPLIED MICROBIOLOGY
- Tackling the Cytotoxic Effect of a Marine Polycyclic Quinone-Type Metabolite: Halenaquinone Induces Molt 4 Cells Apoptosis via Oxidative Stress Combined with the Inhibition of HDAC and Topoisomerase Activities
- (2015) Shou-Ping Shih et al. Marine Drugs
- The Multifaceted Role of Curcumin in Cancer Prevention and Treatment
- (2015) Muthu Shanmugam et al. MOLECULES
- Aceroside VIII is a New Natural Selective HDAC6 Inhibitor that Synergistically Enhances the Anticancer Activity of HDAC Inhibitor in HT29 Cells
- (2015) Hyun-Wook Ryu et al. PLANTA MEDICA
- Curcumin-Mediated HDAC Inhibition Suppresses the DNA Damage Response and Contributes to Increased DNA Damage Sensitivity
- (2015) Shu-Huei Wang et al. PLoS One
- The nucleosome remodeling and deacetylase complex in development and disease
- (2015) Jeannine Basta et al. Translational Research
- Romidepsin targets multiple survival signaling pathways in malignant T cells
- (2015) B C Valdez et al. Blood Cancer Journal
- Inhibition of p300 lysine acetyltransferase activity by luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse model
- (2015) Ruthrotha B. Selvi et al. Oncotarget
- Natural Bioactives in Cancer Treatment and Prevention
- (2015) Yih-Shou Hsieh et al. Biomed Research International
- Vorinostat-An overview
- (2015) AdityaKumar Bubna INDIAN JOURNAL OF DERMATOLOGY
- Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors
- (2014) M. Bots et al. BLOOD
- Resveratrol and cancer: focus on in vivo evidence
- (2014) Lindsay G Carter et al. ENDOCRINE-RELATED CANCER
- PAX1 Methylation as a Potential Biomarker for Cervical Cancer Screening
- (2014) Yuen-Yee Kan et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Posttranslational modifications of histone deacetylases: Implications for cardiovascular diseases
- (2014) Gwang Hyeon Eom et al. PHARMACOLOGY & THERAPEUTICS
- Histone deacetylase inhibitor (HDACI) mechanisms of action: Emerging insights
- (2014) Prithviraj Bose et al. PHARMACOLOGY & THERAPEUTICS
- Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
- (2014) E. Seto et al. Cold Spring Harbor Perspectives in Biology
- Novel Medicines and Strategies in Cancer Treatment and Prevention
- (2014) Chih-Hsin Tang et al. Biomed Research International
- Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer
- (2013) Deepti Shrimali et al. CANCER LETTERS
- Natural Bioactives and Phytochemicals Serve in Cancer Treatment and Prevention
- (2013) Shun-Fa Yang et al. Evidence-based Complementary and Alternative Medicine
- Histone Deacetylase Regulation of ATM-Mediated DNA Damage Signaling
- (2013) K. T. Thurn et al. MOLECULAR CANCER THERAPEUTICS
- Curcumin as a regulator of epigenetic events
- (2013) Marie-Hélène Teiten et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Correction: Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells
- (2013) Sascha Venturelli et al. PLoS One
- SIRT1 activation enhances HDAC inhibition-mediated upregulation of GADD45G by repressing the binding of NF-κB/STAT3 complex to its promoter in malignant lymphoid cells
- (2013) A Scuto et al. Cell Death & Disease
- Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer
- (2012) Muthu K. Shanmugam et al. CANCER LETTERS
- Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells
- (2012) Guang Yan et al. MOLECULAR CARCINOGENESIS
- Natural chalcones as dual inhibitors of HDACs and NF-κB
- (2012) B. ORLIKOVA et al. ONCOLOGY REPORTS
- Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors
- (2012) Geneviève P Delcuve et al. Clinical Epigenetics
- Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo
- (2011) Seung Joon Lee et al. BMC CANCER
- Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma
- (2011) Karen M VanderMolen et al. JOURNAL OF ANTIBIOTICS
- Expression of histone deacetylase 1 correlates with a poor prognosis in patients with adenocarcinoma of the lung
- (2011) Yoshihiro Minamiya et al. LUNG CANCER
- Targeting Cell Signaling and Apoptotic Pathways by Dietary Agents: Role in the Prevention and Treatment of Cancer
- (2011) Muthu Shanmugam et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabinein vitroand in orthotopic mouse model of human pancreatic cancer
- (2010) Kuzhuvelil B. Harikumar et al. INTERNATIONAL JOURNAL OF CANCER
- Histone deacetylase inhibitors (HDACIs). Structure-activity relationships: history and new QSAR perspectives
- (2010) Eleni Pontiki et al. MEDICINAL RESEARCH REVIEWS
- The enhancement of antiproliferative and proapoptotic activity of HDAC inhibitors by curcumin is mediated by Hsp90 inhibition
- (2009) Chiara Giommarelli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model
- (2009) B. Sung et al. MOLECULAR CANCER THERAPEUTICS
- Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
- (2008) W Weichert et al. BRITISH JOURNAL OF CANCER
- Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo
- (2008) W. Weichert et al. CLINICAL CANCER RESEARCH
- Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma
- (2008) L Marquard et al. HISTOPATHOLOGY
- Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis
- (2008) Wilko Weichert et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation